Artisan Partners Limited Partnership Aprea Therapeutics, Inc. Transaction History

Artisan Partners Limited Partnership

$63.7 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 11, 2021	SELL	$4.73 - $8.15 $2.45 Million - $4.22 Million	-517,771 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$4.92 - $30.67 $1.12 Million - $6.95 Million	226,696 Added 77.88%	517,771 $2.55 Million
Q3 2020 Nov 12, 2020	BUY	$21.66 - $38.86 $1.27 Million - $2.28 Million	58,701 Added 25.26%	291,075 $7 Million
Q2 2020 Aug 12, 2020	BUY	$25.47 - $39.69 $78,753 - $122,721	3,092 Added 1.35%	232,374 $9.01 Million
Q1 2020 May 12, 2020	BUY	$31.65 - $45.3 $1.52 Million - $2.18 Million	48,152 Added 26.58%	229,282 $7.97 Million
Q4 2019 Feb 12, 2020	BUY	$18.94 - $49.53 $3.43 Million - $8.97 Million	181,130 New	181,130 $8.31 Million

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,589
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.